Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Financial Statements

2 Followers

Jagsonpal Pharmaceuticals Ltd. Financial Overview

Jagsonpal Pharmaceuticals Ltd.'s market cap is currently ₹14.25B. The company's EPS TTM is ₹; its P/E ratio is 37.13; and it has a dividend yield of 1.24%. Jagsonpal Pharmaceuticals Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₹ 2.87B	₹ 2.69B	₹ 2.09B	₹ 2.37B	₹ 2.18B
Gross Profit	₹ 1.83B	₹ 1.72B	₹ 652.59M	₹ 1.44B	₹ 1.28B
Operating Income	₹ 486.30M	₹ 435.49M	₹ 214.04M	₹ 343.30M	₹ 245.45M
EBITDA	₹ 679.90M	₹ 510.71M	₹ 323.46M	₹ 363.96M	₹ 284.53M
Net Income	₹ 430.82M	₹ 553.61M	₹ 224.63M	₹ 267.21M	₹ 188.55M
Balance Sheet
Cash & Short-Term Investments	₹ 1.06B	₹ 1.29B	₹ 1.48B	₹ 1.15B	₹ 472.77M
Total Assets	₹ 3.17B	₹ 2.78B	₹ 2.17B	₹ 1.95B	₹ 1.68B
Total Debt	₹ 81.65M	₹ 92.39M	₹ 89.41M	₹ 60.01M	₹ 52.47M
Net Debt	₹ -18.77M	₹ -1.19B	₹ -38.19M	₹ -50.52M	₹ -251.35M
Total Liabilities	₹ 405.05M	₹ 383.10M	₹ 296.76M	₹ 360.56M	₹ 375.99M
Stockholders' Equity	₹ 2.76B	₹ 2.40B	₹ 1.87B	₹ 1.59B	₹ 1.31B
Cash Flow
Free Cash Flow	₹ 466.64M	₹ 549.52M	₹ 349.18M	₹ 463.37M	₹ 51.31M
Operating Cash Flow	₹ 468.12M	₹ 553.00M	₹ 351.66M	₹ 466.54M	₹ 55.98M
Investing Cash Flow	₹ -356.49M	₹ -451.47M	₹ -245.48M	₹ -576.71M	₹ -257.79M
Financing Cash Flow	₹ -121.49M	₹ -116.98M	₹ -89.11M	₹ -4.57M	₹ -175.52M

Currency in INR

Jagsonpal Pharmaceuticals Ltd. Earnings and Revenue History

Income Statement >

Jagsonpal Pharmaceuticals Ltd. Debt to Assets

Balance Sheet >

Jagsonpal Pharmaceuticals Ltd. Cash Flow

Cash Flow >

Jagsonpal Pharmaceuticals Ltd. Forecast EPS vs Actual EPS

Earnings >